Sangamo BioSciences Reports Second Quarter 2009 Financi...(s. Actual results may differ from those ...)

Date:7/29/2009

s. Actual results may differ from those projected in forward-looking statements due to risks and uncertainties that exist in the company's operations and business environments. These risks and uncertainties are described more fully in Sangamo's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q as filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and will not be updated.

    SELECTED CONSOLIDATED FINANCIAL DATA
    (in thousands, except per share data)
    (unaudited)

    STATEMENT OF OPERATIONS DATA:

                                         Three Months Ended  Six Months Ended
                                              June 30,          June 30,
                                            -----------        ----------
                                            2009     2008      2009      2008
                                            ----     ----      ----      ----

    Revenues
      Collaboration agreements            $4,213   $2,378    $7,370    $4,462
      Research grants                        513      464       513     1,145
                                           -----    -----     -----     -----
        Total revenues                     4,726    2,842     7,883     5,607

    Operating expenses:
      Research and development             6,877    8,286    14,133    16,929
      General and administrative           3,007    2,545     5,933     5,472
        Total operating expenses           9,884   10,831    20,066    22,401
                                          ------   ------    ------    ------
    Loss from operations                  (5,158)  (7,989)  (12,183)  (16,794)
    Interest and other income, net           647      570       840     1,406
    Net loss                             $(4,511) $(7,419) $(11,343) $(15,388)
                                         =======  =======  ======
'/>"/>
SOURCE  Sangamo BioSciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 
Related biology technology :

1. Sangamo BioSciences Announces Second Quarter 2009 Conference Call and Webcast
2. Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference
3. Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
4. Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species
5. Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast
6. Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results
7. Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
8. Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast
9. Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement
10. Sangamo BioSciences to Present at the 27th Annual J.P. Morgan Healthcare Conference
11. Sangamo BioSciences to Webcast Annual Investor and Analyst Briefing and Presentation at Piper Jaffray Health Care Conference